Valpromide

NERVOUS SYSTEM

Key facts

Valpromide is a drug catalogued in DrugCentral.

• ATC code: N03AG02 (Fatty acid derivatives).
• Molecular formula: C8H17NO; molecular weight 143.23 g/mol.

ATC classification

ATC code	Therapeutic hierarchy
N03AG02	NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Fatty acid derivatives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Poisoning deliberate	245.7
Coma	211.7
Wrong patient received product	90.2
Hypothermia	87.3
Hypotension	86.9
Toxicity to various agents	78.0
Somnolence	72.9
Suicide attempt	71.2
Altered state of consciousness	69.7
Meningioma	61.3
Hepatocellular injury	60.5
Drug interaction	57.7

Chemical structure

• Molecular formula: C₈H₁₇NO
• Molecular weight: 143.23 g/mol
• CAS number: 2430-27-5
• InChIKey: OMOMUFTZPTXCHP-UHFFFAOYSA-N
• PubChem CID: 71113

CCCC(CCC)C(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Valpromide?

Valpromide has the molecular formula C8H17NO and a molecular weight of 143.23 g/mol.

Sources

• DrugCentral drug card 2804 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL93836 — compound record and bioactivity
• PubChem CID 71113 — chemical identifiers
• DrugBank DB04165 — drug record
• FDA UNII RUA6CWU76G — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.